Psoriasis Trial, Recruiting (NCT05503875)

Psoriasis Trial, Recruiting NCT05503875 Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University Condition: Psoriasis

Printed from Voxsanity (voxsanity.com.au) — NCT05503875 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Psoriasis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are between 18 and 75 years of age
People who have moderate to severe chronic psoriasis covering at least 3% of their body surface area
People whose psoriasis has been present for at least 6 months
People whose condition has been assessed as needing systemic (whole-body) treatment, as determined by their doctor
People who have given their written informed consent to participate in the trial
Women who have a negative pregnancy test and who agree to use contraception during the trial

Who may not be able to join:

People who have serious infections, including hepatitis, HIV, or tuberculosis
People who have a known significant allergy to biological medicines
People who have a history of cancer
People who are unwilling or unable to use contraception
People who have serious, unstable, or poorly controlled medical conditions

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 13600516219

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05503875

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase: Not Applicable

Status: Recruiting

Condition: Psoriasis

Trial contact: 13600516219

More information: https://clinicaltrials.gov/study/NCT05503875

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are between 18 and 75 years of age
People who have moderate to severe chronic psoriasis covering at least 3% of their body surface area
People whose psoriasis has been present for at least 6 months
People whose condition has been assessed as needing systemic (whole-body) treatment, as determined by their doctor
People who have given their written informed consent to participate in the trial
Women who have a negative pregnancy test and who agree to use contraception during the trial

Who may not be able to join:

People who have serious infections, including hepatitis, HIV, or tuberculosis
People who have a known significant allergy to biological medicines
People who have a history of cancer
People who are unwilling or unable to use contraception
People who have serious, unstable, or poorly controlled medical conditions

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Registry

ClinicalTrials.gov

Start date

1 January 2023

Est. completion

31 December 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Differences in the number of immune cells (dendritic cells, macrophages) in the lesional skin, non-lesional skin of psoriasis patients and healthy skin.; Molecular analysis of psoriasis lesional skin by single-cell RNA sequencing.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov